The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy

References

• Albrecht H, Hoffmann C, Degen O, Stoehr A, Plettenberg A, Mertenskotter T, Eggers C, Stel'brink HJ (1998). Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 12: 1149–1154.
   PubMed Web of Science ®Google Scholar
• Ammassari A, Cingolani A, Pezzotti P, De Luca DA, Murri R, Giancola ML, Larocca LM, Antinori A (2000). AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology 55: 1194–1200.
   PubMedGoogle Scholar
• Berger JR, Levy RM, Flomenhoft D, Dobbs M (1998). Predic-tive factors for prolonged survival in acquired immuno-deficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 44: 341–349.
   Google Scholar
• Cinque P, Casari S, Bertelli D (1998). Progressive multifocal leukoencephalopathy, HIV, and highly active antiretro-viral therapy. N Engl J Med 339: 848–849.
   Google Scholar
• Cinque P, Vago L, Dahl H, Brytting M, Terreni MR, Fornara C, Racca S, Castagna A, Monforte AD, Wahren B, Lazzarin A, Linde A (1996). Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 10: 951–958.
   PubMed Web of Science ®Google Scholar
• Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE (1999). HAART im-proves prognosis in HIV-associated progressive multif o-cal leukoencephalopathy. Neurology 52: 623–625.
   PubMed Web of Science ®Google Scholar
• De Luca A, Giancola ML, Ammassari A, et al (2000a). The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multi-focal leukoencephalopathy. I Infect Dis 182: 1077–1083.
   PubMed Web of Science ®Google Scholar
• De Luca A, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Paglia MG, Govoni A, Murri R, Testa L, Monforte AD, Antinori A (2000). Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifoc al leukoen-cephalopathy. AIDS 14: F117–121.
   Google Scholar
• DeSimone JA, Pomerantz RJ, Babinchak TJ (2000). Inflam-matory reactions in HIV-1-infected persons after initia-tion of highly active antiretroviral therapy. Ann Intern Med 133: 447–454.
   PubMed Web of Science ®Google Scholar
• Dworkin MS, Wan PC, Hanson DL, Jones JL (1999). Progressive multifocal leukoencephalopathy: improved survival of human immunodeficiency virus-infected pa-tients in the protease inhibitor era. /Infect Dis 180: 621–625.
   PubMed Web of Science ®Google Scholar
• Gasnault J, Taoufik Y, Goujard C, Kousignian P, Abbed K, Boue F, Dussaix E, Delfraissy JF (1999). Pro-longed survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretrovi-ral therapy. J NeuroVirol 5: 421–429.
   PubMed Web of Science ®Google Scholar
• Giudici B, Vaz B, Bossolasco S, Casari S, Brambilla AM, Luke W, Lazzarin A, Weber T, Cinque P (2000). Highly active antiretroviral therapy and progressive multifo-cal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 30: 95–99.
   PubMed Web of Science ®Google Scholar
• Hall CD, Dafni U, Simpson D, Clifford D, Wetherill PE, Cohen B, McArthur J, Hollander H, Yainnoutsos C, Major E, Millar L, Timpone J (1998). Failure of cytarabine in progressive multifoc al leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. NEng/JMed 338: 1345–1351.
   Google Scholar
• Koralnik IJ, Du Pasquier RA, Letvin NL (2001). JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. I Virol 75: 3483–3487.
   PubMed Web of Science ®Google Scholar
• Marra CM, Rajicic N, Barker DE, Cohen B, Clifford D and the ACTG 363 Team (2001). Prospective pilot study of cidofovir for HIV-associated progressive mul-tifocal leukoencephalopathy (PML). The 8th conference on retroviruses and opportunistic infections, Chicago, Illinois, February 4–8,2001. Abstract 596.
   Google Scholar
• Miralles P, Berenguer J, Garcia de Viedma D, Padilla B, Cosin J, Lopez-Bernaldo de Quiros JC, Munoz L, Moreno S, Bouza E (1998). Treatment of AIDS-associated pro-gressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 12: 2467–2472.
   PubMed Web of Science ®Google Scholar
• Miralles P, Berenguer J, Lacruz C, Lopez JC, Cosin J, Padilla B, Mulioz L, Garcra de Viedma D (2000). Paradoxical Worsening of AIDS-Associated Progressive Multifocal Leukoencephalopathy Following HAART. The 8th con-ference on retroviruses and opportunistic infections, Chicago, Illinois, February 4–8,2001. Abstract 598.
   Google Scholar
• Panel on Clinical Practices for Treatment of HIV Infection, Department of Health and Human Services (DHHS) and the Henry J Kaiser Foundation (2001). Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents (http://www.hivatis.org).
   Google Scholar
• Sala M, Vartanian J-P, Kousignian P, Delfraissy JF, Taoufik Y, Wain-Hobson S, Gasnault J (2001). Progressive multifocal leukoencephalopathy in human immuno-deficiency virus type-1 infected patients: absence of correlation between JC virus neurovirulence and polymorphisms in the transcriptional control region and the major capsid protein loci. I Gen Virol 82: 899–907.
   PubMed Web of Science ®Google Scholar
• Tantisiriwat W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ (1999). Progressive multifocal leukoen-cephalopathy in patients with AIDS receiving highly ac-tive antiretroviral therapy. Clin Infect Dis 28: 1152–1154.
   PubMedGoogle Scholar
• The Studies of Ocular Complications of AIDS research group (SOCA) in collaboration with the AIDS clin-ical trials group (2000). Long-term follow-up of pa-tients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC peripheral cy-tomegalovirus retinitis trial. AIDS 14: 1571–1581.
   Google Scholar